BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 1686875)

  • 1. Mechanisms of chemical cooperative carcinogenesis by epidermal Langerhans cells.
    Lewis JM; Bürgler CD; Fraser JA; Liao H; Golubets K; Kucher CL; Zhao PY; Filler RB; Tigelaar RE; Girardi M
    J Invest Dermatol; 2015 May; 135(5):1405-1414. PubMed ID: 25233073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered presence of extra cellular matrix components in murine skin cancer: Modulation by
    Chugh NA; Koul A
    J Tradit Complement Med; 2021 May; 11(3):197-208. PubMed ID: 34012866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse model.
    Okumura K; Morinaga T; Saito M; Tokunaga Y; Otoyama K; Tanaka S; Isogai E; Kawazu M; Togashi Y; Hasegawa Y; Wakabayashi Y
    Cancer Sci; 2024 Jun; ():. PubMed ID: 38898727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repression of M-phase phosphoprotein 8 inhibits melanoma growth and metastasis
    Yuan B; Lin L; Ying ZY; Ying MX; Zhou QY; Shi L
    Int J Clin Exp Pathol; 2017; 10(12):12003-12009. PubMed ID: 31966565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VILIP-1 expression in vivo results in decreased mouse skin keratinocyte proliferation and tumor development.
    Fu J; Jin F; Zhang J; Fong K; Bassi DE; Lopez De Cicco R; Ramaraju D; Braunewell KH; Conti C; Benavides F; Klein-Szanto AJ
    PLoS One; 2010 Apr; 5(4):e10196. PubMed ID: 20419170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential study of gamma-glutamyltransferase during complete and two-stage mouse skin carcinogenesis.
    Chiba M; Maley MA; Klein-Szanto AJ
    Cancer Res; 1986 Jan; 46(1):259-63. PubMed ID: 2866031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
    Iversen OH
    APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of terminal differentiation-resistant epidermal cells in mouse skin and in papillomas by different initiators during two-stage carcinogenesis.
    Miller DR; Viaje A; Rotstein J; Aldaz CM; Conti CJ; Slaga TJ
    Cancer Res; 1989 Jan; 49(2):410-4. PubMed ID: 2491955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
    Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic potential of mouse skin carcinomas produced by different protocols of chemical carcinogenesis.
    Chiba M; Aldaz CM; Conti CJ; Klein-Szanto AJ
    Invasion Metastasis; 1991; 11(5):288-96. PubMed ID: 1686875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three stage carcinogenesis in mouse skin--recent results and present status of an advanced model system of chemical carcinogenesis.
    Hecker E
    Toxicol Pathol; 1987; 15(2):245-58. PubMed ID: 3112923
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.